1384 LNK101, a highly differentiated T-cell engager (TCE) targeting CD3 and mesothelin (MSLN) in solid tumors

oleh: Linda Santiago, Jane Carter, Ashok Bandaranayake, Colin Correnti, Ida Lin, Man Kid Chan, Scott Delbecq, Midori Clarke, Eric Gruff, William Bracken, David Meininger, Diana Hausman, Christopher Mehlin

Format: Article
Diterbitkan: BMJ Publishing Group 2023-11-01

Deskripsi

No description available for this item.